{"id":"https://openalex.org/W4283395166","doi":"https://doi.org/10.1158/1538-7445.am2022-lb216","title":"Abstract LB216: Pre-clinical characterization of NGM831, an ILT3 antagonist antibody for the treatment of solid tumors","display_name":"Abstract LB216: Pre-clinical characterization of NGM831, an ILT3 antagonist antibody for the treatment of solid tumors","publication_year":2022,"publication_date":"2022-06-15","ids":{"openalex":"https://openalex.org/W4283395166","doi":"https://doi.org/10.1158/1538-7445.am2022-lb216"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2022-lb216","doi":"https://doi.org/10.1158/1538-7445.am2022-lb216","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-lb216","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Peirong Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121250","display_name":"NGM Biopharmaceuticals (United States)","ror":"https://ror.org/01x8fkj71","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121250"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peirong Chen","raw_affiliation_strings":["1NGM Biopharmaceuticals, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NGM Biopharmaceuticals, South San Francisco, CA","institution_ids":["https://openalex.org/I4210121250"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023977277","display_name":"Suzanne Crawley","orcid":"https://orcid.org/0009-0007-6411-1294","observed_orcids":["https://orcid.org/0009-0007-6411-1294"]},"institutions":[{"id":"https://openalex.org/I4210121250","display_name":"NGM Biopharmaceuticals (United States)","ror":"https://ror.org/01x8fkj71","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121250"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suzanne C. Crawley","raw_affiliation_strings":["1NGM Biopharmaceuticals, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NGM Biopharmaceuticals, South San Francisco, CA","institution_ids":["https://openalex.org/I4210121250"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003709535","display_name":"Vicky Y. Lin","orcid":"https://orcid.org/0009-0000-9324-4933","observed_orcids":["https://orcid.org/0009-0000-9324-4933"]},"institutions":[{"id":"https://openalex.org/I4210121250","display_name":"NGM Biopharmaceuticals (United States)","ror":"https://ror.org/01x8fkj71","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121250"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vicky Y. Lin","raw_affiliation_strings":["1NGM Biopharmaceuticals, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NGM Biopharmaceuticals, South San Francisco, CA","institution_ids":["https://openalex.org/I4210121250"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Varun Kapoor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121250","display_name":"NGM Biopharmaceuticals (United States)","ror":"https://ror.org/01x8fkj71","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121250"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Varun Kapoor","raw_affiliation_strings":["1NGM Biopharmaceuticals, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NGM Biopharmaceuticals, South San Francisco, CA","institution_ids":["https://openalex.org/I4210121250"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075542172","display_name":"Kevin J. Paavola","orcid":"https://orcid.org/0009-0009-4884-9103","observed_orcids":["https://orcid.org/0009-0009-4884-9103"]},"institutions":[{"id":"https://openalex.org/I4210121250","display_name":"NGM Biopharmaceuticals (United States)","ror":"https://ror.org/01x8fkj71","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121250"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin J. Paavola","raw_affiliation_strings":["1NGM Biopharmaceuticals, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NGM Biopharmaceuticals, South San Francisco, CA","institution_ids":["https://openalex.org/I4210121250"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073838540","display_name":"Hung-I Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121250","display_name":"NGM Biopharmaceuticals (United States)","ror":"https://ror.org/01x8fkj71","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121250"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hung-I Chen","raw_affiliation_strings":["1NGM Biopharmaceuticals, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NGM Biopharmaceuticals, South San Francisco, CA","institution_ids":["https://openalex.org/I4210121250"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068847926","display_name":"Joshua S. Lichtman","orcid":"https://orcid.org/0000-0002-5256-6773","observed_orcids":["https://orcid.org/0000-0002-5256-6773"]},"institutions":[{"id":"https://openalex.org/I4210121250","display_name":"NGM Biopharmaceuticals (United States)","ror":"https://ror.org/01x8fkj71","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121250"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joshua S. Lichtman","raw_affiliation_strings":["1NGM Biopharmaceuticals, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NGM Biopharmaceuticals, South San Francisco, CA","institution_ids":["https://openalex.org/I4210121250"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045421477","display_name":"Betty Li","orcid":"https://orcid.org/0009-0006-7293-9465","observed_orcids":["https://orcid.org/0009-0006-7293-9465"]},"institutions":[{"id":"https://openalex.org/I4210121250","display_name":"NGM Biopharmaceuticals (United States)","ror":"https://ror.org/01x8fkj71","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121250"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Betty Li","raw_affiliation_strings":["1NGM Biopharmaceuticals, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NGM Biopharmaceuticals, South San Francisco, CA","institution_ids":["https://openalex.org/I4210121250"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093990194","display_name":"Kalyani Mondal","orcid":"https://orcid.org/0009-0006-8415-4892","observed_orcids":["https://orcid.org/0009-0006-8415-4892"]},"institutions":[{"id":"https://openalex.org/I4210121250","display_name":"NGM Biopharmaceuticals (United States)","ror":"https://ror.org/01x8fkj71","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121250"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kalyani Mondal","raw_affiliation_strings":["1NGM Biopharmaceuticals, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NGM Biopharmaceuticals, South San Francisco, CA","institution_ids":["https://openalex.org/I4210121250"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049632643","display_name":"Alan K. Kutach","orcid":"https://orcid.org/0000-0001-9672-8175","observed_orcids":["https://orcid.org/0000-0001-9672-8175"]},"institutions":[{"id":"https://openalex.org/I4210121250","display_name":"NGM Biopharmaceuticals (United States)","ror":"https://ror.org/01x8fkj71","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121250"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan K. Kutach","raw_affiliation_strings":["1NGM Biopharmaceuticals, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NGM Biopharmaceuticals, South San Francisco, CA","institution_ids":["https://openalex.org/I4210121250"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100322983","display_name":"Yan Wang","orcid":"https://orcid.org/0000-0003-4779-9967","observed_orcids":["https://orcid.org/0000-0003-4779-9967","https://orcid.org/0009-0006-0078-7714"]},"institutions":[{"id":"https://openalex.org/I4210121250","display_name":"NGM Biopharmaceuticals (United States)","ror":"https://ror.org/01x8fkj71","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121250"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yan Wang","raw_affiliation_strings":["1NGM Biopharmaceuticals, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NGM Biopharmaceuticals, South San Francisco, CA","institution_ids":["https://openalex.org/I4210121250"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043238367","display_name":"Daniel D. Kaplan","orcid":"https://orcid.org/0000-0001-8297-560X","observed_orcids":["https://orcid.org/0000-0001-8297-560X"]},"institutions":[{"id":"https://openalex.org/I4210121250","display_name":"NGM Biopharmaceuticals (United States)","ror":"https://ror.org/01x8fkj71","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121250"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel D. Kaplan","raw_affiliation_strings":["1NGM Biopharmaceuticals, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NGM Biopharmaceuticals, South San Francisco, CA","institution_ids":["https://openalex.org/I4210121250"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047002376","display_name":"Julie M. Roda","orcid":"https://orcid.org/0000-0001-5631-9908","observed_orcids":["https://orcid.org/0000-0001-5631-9908"]},"institutions":[{"id":"https://openalex.org/I4210121250","display_name":"NGM Biopharmaceuticals (United States)","ror":"https://ror.org/01x8fkj71","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121250"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie M. Roda","raw_affiliation_strings":["1NGM Biopharmaceuticals, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NGM Biopharmaceuticals, South San Francisco, CA","institution_ids":["https://openalex.org/I4210121250"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210121250"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"12_Supplement","first_page":"LB216","last_page":"LB216"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.6762999892234802,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.6762999892234802,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.18400000035762787,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.08560000360012054,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lilrb4","display_name":"LILRB4","score":0.9269999861717224},{"id":"https://openalex.org/keywords/fibronectin","display_name":"fibronectin","score":0.796999990940094},{"id":"https://openalex.org/keywords/tumor-associated-myeloid-cells","display_name":"tumor-associated myeloid cells","score":0.8730000257492065},{"id":"https://openalex.org/keywords/myeloid-cell-reprogramming","display_name":"myeloid cell reprogramming","score":0.7440000176429749},{"id":"https://openalex.org/keywords/dendritic-cell-maturation","display_name":"dendritic cell maturation","score":0.7429999709129333},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7860000133514404},{"id":"https://openalex.org/keywords/apolipoprotein-e","display_name":"apolipoprotein E","score":0.7160000205039978},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.7360000014305115},{"id":"https://openalex.org/keywords/pembrolizumab-combination","display_name":"pembrolizumab combination","score":0.8899999856948853},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.6050000190734863},{"id":"https://openalex.org/keywords/cynomolgus-monkeys","display_name":"Macaca fascicularis","score":0.746999979019165}],"concepts":[{"id":"https://openalex.org/C2778170410","wikidata":"https://www.wikidata.org/wiki/Q506253","display_name":"Dendritic cell","level":3,"score":0.6035827398300171},{"id":"https://openalex.org/C39347974","wikidata":"https://www.wikidata.org/wiki/Q21135811","display_name":"CD40","level":4,"score":0.47012436389923096},{"id":"https://openalex.org/C2778513237","wikidata":"https://www.wikidata.org/wiki/Q419553","display_name":"CD14","level":3,"score":0.4668014645576477},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.44359689950942993},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.44215258955955505},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.417972207069397},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4135544002056122},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.4131513237953186},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4094806909561157},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.40689027309417725},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.39125239849090576},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3789348006248474},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2823229432106018},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.12212777137756348},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09184408187866211},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.07851019501686096}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2022-lb216","doi":"https://doi.org/10.1158/1538-7445.am2022-lb216","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-lb216","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3193307873","https://openalex.org/W4200395343","https://openalex.org/W4393096737","https://openalex.org/W4416447453","https://openalex.org/W4308402612","https://openalex.org/W4393093392","https://openalex.org/W3176480113","https://openalex.org/W1570842557","https://openalex.org/W3113663408","https://openalex.org/W1519460121"],"abstract_inverted_index":{"Abstract":[0],"Suppressive":[1],"myeloid":[2,25,58,270],"cells":[3,26,118,170,187,229,247,252],"inhibit":[4],"antitumor":[5],"immunity":[6],"by":[7],"preventing":[8],"T":[9,251],"cell":[10,59,143,271],"responses.":[11],"Immunoglobulin-like":[12],"transcript":[13],"3":[14],"(ILT3,":[15],"also":[16],"known":[17],"as":[18,37,47,208],"LILRB4)":[19],"is":[20,294],"highly":[21],"expressed":[22],"on":[23],"tumor-associated":[24],"and":[27,84,91,94,106,131,139,148,162,211,215,268,286],"promotes":[28,57],"their":[29,127,150,191,202,217],"suppressive":[30],"phenotype.":[31,178],"Our":[32],"team":[33],"recently":[34],"identified":[35],"fibronectin":[36,105,125],"a":[38,48,73,109,175],"functional":[39],"ligand":[40,213],"for":[41,300,353,366],"ILT3.":[42],"The":[43],"fibronectin-ILT3":[44],"interaction":[45,97],"serves":[46],"\u201cstromal":[49],"checkpoint\u201d":[50],"through":[51],"which":[52],"the":[53,62,68,96,122,224,243,276,280,301,354,363],"extracellular":[54],"matrix":[55],"actively":[56],"suppression":[60],"in":[61,121,155,196,253,287,307],"tumor":[63],"microenvironment.":[64],"We":[65],"now":[66],"report":[67],"pre-clinical":[69],"characterization":[70,346],"of":[71,82,98,115,124,129,141,152,184,193,219,226,232,245,279,303,347,356,362],"NGM831,":[72,348],"humanized":[74],"IgG1":[75],"(N297G)":[76],"antibody":[77,283,352],"that":[78,168,221,262],"binds":[79],"to":[80,174,198,204,230,241,248,296],"ILT3":[81,99,281,350],"human":[83],"cynomolgus":[85],"monkey":[86],"origin":[87],"with":[88,100,119,180,188,239,289],"high":[89],"specificity":[90],"sub-nM":[92],"affinity":[93],"blocks":[95],"both":[101],"its":[102],"reported":[103],"ligands,":[104],"ApoE.":[107],"In":[108,234],"gene":[110],"expression":[111,128,151],"profiling":[112],"experiment,":[113],"treatment":[114,183,302,355],"tolerogenic":[116,185],"dendritic":[117,142,186,246],"NGM831":[120,189,236,263,284,293],"presence":[123],"decreased":[126],"inhibitory":[130],"scavenger":[132],"receptors":[133],"(CD163,":[134],"MRC1,":[135],"MARCO,":[136],"STAB1,":[137],"LILRB2)":[138],"markers":[140],"immaturity":[144],"(CD14,":[145],"CD209,":[146],"FOLR2)":[147],"increased":[149,190,216],"genes":[153],"involved":[154],"antigen":[156],"presentation":[157],"(TNFSF14,":[158],"DCSTAMP,":[159],"CD82,":[160],"OLR1)":[161],"TH1":[163],"polarization":[164],"(SPP1,":[165],"TBX21),":[166],"suggesting":[167],"these":[169,181,259],"had":[171],"been":[172],"remodeled":[173],"more":[176],"stimulatory":[177],"Consistent":[179],"observations,":[182],"production":[192,218],"pro-inflammatory":[194],"cytokines":[195],"response":[197],"Fc\u0263R":[199],"ligation,":[200],"restored":[201],"responsiveness":[203],"maturation":[205],"stimuli":[206],"such":[207],"lipopolysaccharide":[209],"(LPS)":[210],"CD40":[212],"(CD40L),":[214],"chemokines":[220],"could":[222],"induce":[223],"migration":[225],"other":[227],"immune":[228,290],"sites":[231],"inflammation.":[233],"addition,":[235],"acted":[237],"synergistically":[238],"pembrolizumab":[240],"increase":[242],"ability":[244],"stimulate":[249],"allogeneic":[250],"mixed":[254],"lymphocyte":[255],"reactions.":[256],"Taken":[257],"together,":[258],"results":[260],"demonstrate":[261],"can":[264],"block":[265],"fibronectin-mediated":[266],"immunosuppression":[267],"promote":[269],"reprogramming.":[272],"These":[273],"data":[274],"support":[275],"clinical":[277,298],"development":[278],"antagonist":[282,351],"alone":[285],"combination":[288],"checkpoint":[291],"blockade.":[292],"expected":[295],"enter":[297],"trials":[299],"advanced":[304],"solid":[305,357],"tumors":[306,358],"early":[308],"2022.":[309],"Citation":[310],"Format:":[311],"Peirong":[312],"Chen,":[313,326],"Suzanne":[314],"C.":[315],"Crawley,":[316],"Vicky":[317],"Y.":[318],"Lin,":[319],"Varun":[320],"Kapoor,":[321],"Kevin":[322],"J.":[323],"Paavola,":[324],"Hung-I":[325],"Joshua":[327],"S.":[328],"Lichtman,":[329],"Betty":[330],"Li,":[331],"Kalyani":[332],"Mondal,":[333],"Alan":[334],"K.":[335],"Kutach,":[336],"Yan":[337],"Wang,":[338],"Daniel":[339],"D.":[340],"Kaplan,":[341],"Julie":[342],"M.":[343],"Roda.":[344],"Pre-clinical":[345],"an":[349],"[abstract].":[359],"In:":[360],"Proceedings":[361],"American":[364],"Association":[365],"Cancer":[367,378],"Research":[368],"Annual":[369],"Meeting":[370],"2022;":[371],"2022":[372],"Apr":[373],"8-13.":[374],"Philadelphia":[375],"(PA):":[376],"AACR;":[377],"Res":[379],"2022;82(12_Suppl):Abstract":[380],"nr":[381],"LB216.":[382]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2022-06-25T00:00:00"}